Requisite Capital Management LLC acquired a new position in Danaher Corporation (NYSE:DHR – Free Report) during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 3,286 shares of the conglomerate’s stock, valued at approximately $627,000.
A number of other hedge funds have also recently made changes to their positions in DHR. Main Street Group LTD purchased a new stake in Danaher in the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in shares of Danaher during the second quarter worth $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the third quarter worth $25,000. Elevated Capital Advisors LLC acquired a new stake in shares of Danaher in the fourth quarter valued at $26,000. Finally, WFA of San Diego LLC acquired a new stake in shares of Danaher in the second quarter valued at $26,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.
Danaher Trading Down 0.0%
DHR opened at $202.44 on Tuesday. Danaher Corporation has a 12 month low of $160.93 and a 12 month high of $242.80. The stock has a market capitalization of $142.31 billion, a price-to-earnings ratio of 35.96, a PEG ratio of 2.52 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. The business has a fifty day moving average price of $193.52 and a 200 day moving average price of $192.67.
Analyst Upgrades and Downgrades
DHR has been the topic of several research reports. Weiss Ratings raised Danaher from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, July 15th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Guggenheim cut their price target on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a research note on Wednesday, July 22nd. Piper Sandler initiated coverage on shares of Danaher in a research report on Thursday, June 11th. They set a “neutral” rating and a $200.00 price target on the stock. Finally, UBS Group lowered their price objective on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, Danaher currently has an average rating of “Moderate Buy” and a consensus price target of $228.91.
Get Our Latest Report on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Recommended Stories
- Five stocks we like better than Danaher
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
